Drug Type Small molecule drug |
Synonyms- |
Target |
Action modulators |
Mechanism TNF-α modulators(Tumor necrosis factor α modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Autoimmune Diseases | Preclinical | United States | 04 Mar 2025 | |
| Cardiovascular Diseases | Preclinical | United States | 04 Mar 2025 | |
| Eye Diseases | Preclinical | United States | 04 Mar 2025 | |
| Inflammation | Preclinical | United States | 04 Mar 2025 | |
| Metabolic Diseases | Preclinical | United States | 04 Mar 2025 | |
| Neoplasms | Preclinical | United States | 04 Mar 2025 | |
| Pain | Preclinical | United States | 04 Mar 2025 |





